Improving childhood vaccination coverage rates: the case of fourth dose of DTaP
Based on the most recently available national data, vaccination coverage for the combined seven-vaccine series recommended by age 24 months remains substantially below the Healthy People 2020 target of 80%. One focus for improvement is the lack of timely administration of the fourth dose of DTaP vac...
Saved in:
Main Authors: | Sarah J. Clark (Author), Anne E. Cowan (Author), Katelyn Wells (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016)
by: Andrea Guerra, et al.
Published: (2024) -
The Implementation of Pentavalent Vaccine DTaP/IPV/Hib within National Immunization Schedule
by: Irina V. Mikheeva, et al.
Published: (2019) -
A review of the DTaP-IPV-HB-PRP-T Hexavalent vaccine in pediatric patients
by: Andrew Dakin, et al.
Published: (2023) -
Immunogenicity and safety of DTaP/Hib combined vaccination at different inoculation sites among infants
by: Zhen-jiang LIU, et al.
Published: (2022) -
DTaP5-IPV-Hib-HepB, a hexavalent vaccine for infants and toddlers
by: Andrew W. Lee, et al.
Published: (2017)